No influence of the polymorphisms CYP2C19 and CYP2D6 on the efficacy of cyclophosphamide, thalidomide, and bortezomib in patients with Multiple Myeloma (Q33649116)
Jump to navigation
Jump to search
scientific article published on 4 August 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No influence of the polymorphisms CYP2C19 and CYP2D6 on the efficacy of cyclophosphamide, thalidomide, and bortezomib in patients with Multiple Myeloma |
scientific article published on 4 August 2010 |
Statements
1 reference
No influence of the polymorphisms CYP2C19 and CYP2D6 on the efficacy of cyclophosphamide, thalidomide, and bortezomib in patients with Multiple Myeloma (English)
1 reference
Thomas Werge
1 reference
Karen Søeby
1 reference
Tobias W Klausen
1 reference
Niels Abildgaard
1 reference
Niels F Andersen
1 reference
Peter Gimsing
1 reference
Henrik Gregersen
1 reference
Henrik B Rasmussen
1 reference
4 August 2010
1 reference
1 reference
10
1 reference
404
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference